Xenex

Company Summary

Xenex Disinfection Services offers pulsed xenon ultraviolet-C room disinfection systems to reduce various classes of healthcare-associated infections (HAIs)

Transaction Overview

In September 2018, the Company's Board of Directors and principal investors(including representatives from Battery Ventures, EW Healthcare, Malin, Piper Jaffray, RK Ventures, Sequel Ventures, and Tectonic Ventures) approved the Singapore Financing Pathway

Significance of the Transaction

Healthios Role

$100MM credit facility from Hitachi has been put in place
The LightStrike pulsed xenon disinfection robots is the first ultraviolet (UV) disinfection technology proven to deactivate the actual SARS-CoV-2(Severe Acute Respiratory Syndrome coronavirus 2)
Mayo Clinic expanded pulsed xenon UV room disinfection to 14 additional hospital units with high rates of C. diff infection utilizing 12 robots after significant C. dif infection rate reductions in the intervention units
Ab Medica chooses Xenex LightStrike Germ-Zapping Robots to disinfect healthcare facilities in Italy
Ab Medica chooses Xenex LightStrike Germ-Zapping Robots to disinfect healthcare facilities in Japan

If you would like to learn more information about this transaction contact us below.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Private Placement

Xenex

Has completed a credit financing of $100 million

The undersigned acted as exclusive advisor to Xenex